Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. comfyt

ComFyt

The revolution of the Compression Therapy Market: an easy-to-wear and comfortable compression stocking based on Electro-Active Polymers technology.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 ComFyt project word cloud

Explore the words cloud of the ComFyt project. It provides you a very rough idea of what is the project "ComFyt" about.

global    eliminates    patient    elastimed    optimal    plastic    prostate    despite    motor    contractions    mobility    pressure    body    stay    disability    circulation    treatment    reduce    wearable    difficulties    mimic    chronic    thrombosis    esteem    people    lymphatic    innovative    insufficiency    employing    social    gender    pregnancy    discomfort    image    age    thromboembolism    polymers    compression    solution    constant    flat    decrease    therapy    natural    eap    mechanical    proprietary    yearly    events    lymphedema    quality    calf    venous    disease    diabetic    muscle    heredity    market    blood    depression    activation    rate    combined    suffering    isolation    actuators    deep    solutions    electro    incidence    stocking    rhythmic    coping    vein    vte    lower    diseases    compliance    manufacturing    worldwide    constructed    approximately    cancer    hospitalization    stockings    elderly    burden    active    breakthrough    limbs    dvt    seek    linear    crashes    population    lifestyle    intermittent    conditioning    representing    life    vehicle    economic    cvi    self    deformation    material    soft    continues    kill    pain    components    options    breast    comfyt    million    aids    altered    sleeve   

Project "ComFyt" data sheet

The following table provides information about the project.

Coordinator		 ELASTIMED LTD 

Organization address
address: HATCHELET 17
city: MISGAV IP
postcode: 2017900
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Israel [IL]
 Project website http://www.elastimed.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.5. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced manufacturing and processing)
2. H2020-EU.2.1.3. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials)
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-06-01   to  2017-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ELASTIMED LTD IL (MISGAV IP) coordinator 50˙000.00

Map

 Project objective

ComFyt is a novel compression therapy stocking employing a proprietary material which eliminates the discomfort and the difficulties of traditional compression stockings. ElastiMed has identified the potential of the technology in the method of manufacturing and processing Electro-Active Polymers (EAP). The material is a soft plastic, constructed flat, with large deformation and linear activation being a unique solution, optimal for wearable devices. These actuators are able to mimic the rhythmic natural calf muscle contractions, leading to the optimal blood circulation, representing a breakthrough in the Compression Therapy. Compression Therapy is based on a mechanical principle of applying a constant or intermittent pressure on the lower limbs using a wearable sleeve or stocking. Despite the many treatment options available, the market is suffering from a low compliance rate and continues to seek innovative solutions that will reduce patient’s discomfort, decrease hospitalization stay, and improve the patient quality of life. Venous and lymphatic diseases such as Venous Thromboembolism (VTE), Chronic Venous Insufficiency (CVI), Deep Vein Thrombosis (DVT) and Lymphedema affect a large population worldwide. Age, gender, heredity, pregnancy and lifestyle are conditioning factors. Pain, mobility difficulties, reduced self-esteem, social isolation, disability to work, altered body image and depression affect the quality of life of the elderly and in general of people coping with venous and lymphatic diseases. Yearly, there are approximately 10 million cases of VTE worldwide. VTE-related events kill more people than AIDS, breast cancer, prostate cancer and motor vehicle crashes combined in Europe and U.S. A growing elderly and diabetic population are also key components in the incidence of venous diseases. In addition to disease burden, venous and lymphatic diseases cause significant global economic burden.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "COMFYT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "COMFYT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.5.;H2020-EU.2.1.3.;H2020-EU.2.3.1.;H2020-EU.2.1.2.)

NAS (2018)

Nexilis augmentation system

Read More  

Gri3D (2018)

The industrialization and market entry of a novel bioengineered hydrogel grid to standardize stem cell cultures for precision medicine.

Read More  

CGM (2018)

A next generation nano media tailored to capture and recycle hazardous micropollutants in contaminated industrial wastewater.

Read More